7
years

Years of Experience

3/17

Member Since


Big 4 Accounting
Top Consulting Firms

Experience

 
Regeneron Pharmaceuticals Inc Accounting
MBA Summer Intern
06/2016 - 08/2016
• Identified and analyzed actual historical costs of production. Provided insights in improvement of production costs allocation base leading to 8% improvement of manufacturing KPI and 6% more efficient utilization of production facility.
• Developed R&D costs forecasting stochastic model, resulting in up to 30% more accurate forecasting and decreasing budget preparation time by 20%.
• Prepared updated five-year financial statement forecast on changes in alliance finance conditions.

Gazprom Accounting
Head of Internal Audit Department
04/2015 - 07/2015
• Detected funds and finished-goods embezzlement, totaling 15% of branch’s revenue.
• Redesigned technical services and document circulation processes, and developed internal controls that reduced time of connecting new customers to the gas pipeline by 20% and reduced fraud risk.
• Established hedging strategy for gas prepayment cash inflows, saving ~2% of FY15Q2 revenue.

KPMG Accounting
Deal Advisory Consultant/ Senior Auditor
09/2011 - 04/2015
• Led due diligence of Kazakhstan banks, pharmaceutical companies, and a US IT company on the buy-side.
• Supported a US Fortune 500 company in the acquisition of an Azerbaijani petrochemical firm.
• Analyzed and developed portfolio of foreign exchange knock-out options for real estate holdings.
• Supervised a 3-5-person audit teams in pharmaceutical and oil & gas sectors. Successfully met a challenging deadline a first-time adoption of IFRS financial statement company.

KYRGYZTELECOM OJSC Accounting
Financial Planning and Analysis Division
07/2009 - 09/2011
• Coordinated managerial accounting division’s key processes and supervised three employees.
• Managed transfer pricing processes within intra branches operations.
• Implemented ERP system at eight regional branches in 85% of budgeted time.
• Implemented Activity Based Costing, which led to 9% cost optimization of loss-making activities.